NCT04803565

Brief Summary

This study aims to assess the efficacy of custom-made shoe insoles, for subjects with Parkinson's Disease (PD). To do that, a sample of PD subjects has been randomly assigned to an intervention group that will receive the custom-made insoles or a control group that will receive a sham insole without any specific manufacturing. Both groups will receive Physiotherapy and Occupational Therapy according to PD rehabilitation guidelines. The principal outcome will be the Time Up\&Go test time, secondary outcomes 10 Meters Walking test speed, Berg Balance Scale score, SF12 score, and orthesis liking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 4, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

March 4, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

October 3, 2023

Status Verified

September 1, 2023

Enrollment Period

1.8 years

First QC Date

March 4, 2021

Last Update Submit

October 2, 2023

Conditions

Keywords

Parkinson DiseaseFoot OrthosesRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Change in Time Up&Go test

    Change from Baseline (without insoles (T0) and with insoles (T1)) Time Up\&Go at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))

    Baseline, at 10 weeks, and at 16 weeks.

Secondary Outcomes (15)

  • Change in 10 Meters walking test Speed

    Baseline, at 10 weeks, and at 16 weeks.

  • Change in Berg Balance Scale Score

    Baseline, at 10 weeks, and at 16 weeks.

  • Change in Short-Form12 score

    Baseline, at 10 weeks, and at 16 weeks.

  • Change in Likert scale 4 points

    Baseline, at 10 weeks, and at 16 weeks.

  • Change in 10 Meters Walking Test cadence

    Baseline, at 10 weeks, and at 16 weeks.

  • +10 more secondary outcomes

Study Arms (2)

Custom-Made Insole

EXPERIMENTAL

This Group will receive a custom-made shoe insole designed on the foot shape of the subjects. The group will also receive Physiotherapy and Occupational Therapy according to current guidelines

Device: Custom-made shoe insole

Sham Insole

SHAM COMPARATOR

This group will receive a Sham shoe insole without any specific custom-made design. The group will also receive Physiotherapy and Occupational Therapy according to current guidelines

Device: Sham conventional Insole

Interventions

Subjects will receive a custom-made shoe insole designed on the patient's foot and shoes. The subjects should wear the insole for at least 6 hours per day.

Custom-Made Insole

Subjects will receive a conventional insole without any specific property (sham insole)

Sham Insole

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects with Idiopathic Parkinson's Disease;
  • Age \> 18 years;
  • Subjects should be in a positive therapeutic window or in the ON phase during the evaluations;
  • Subjects must be able to walk at least 10 meters independently with or without any walking aid.

You may not qualify if:

  • Not clinical stable subjects;
  • SUbjects in OFF phase during the evaluations;
  • Other neurological conditions (e.g. stroke, peripheral neuropathies, etc.);
  • Other pathologies that can negatively influence the subject's walking ability (e.g. surgery at the lower limbs in the previous 6 months, important deformities at the lower limbs, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Fondazione Don Carlo Gnocchi

Milan, 20148, Italy

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2021

First Posted

March 17, 2021

Study Start

March 4, 2021

Primary Completion

December 31, 2022

Study Completion

March 30, 2023

Last Updated

October 3, 2023

Record last verified: 2023-09

Locations